GRIN1 and encephalitis: Defining further the pathogenic effects of GluN1 antibodies on NMDAR function will contribute to our understanding of how function of surface NMDARs may be disrupted, even at later stages of antibody exposure and disease, and provide insights into novel therapeutic targets for anti-NMDAR encephalitis.